Literature DB >> 24849348

Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.

Qiu-Lan Ma1, Xiaohong Zuo2, Fusheng Yang1, Oliver J Ubeda1, Dana J Gant1, Mher Alaverdyan1, Nicolae C Kiosea1, Sean Nazari1, Ping Ping Chen1, Fatiha Nothias3, Piu Chan4, Edmond Teng1, Sally A Frautschy5, Greg M Cole5.   

Abstract

Hyperphosphorylation and accumulation of tau aggregates are prominent features in tauopathies, including Alzheimer's disease, but the impact of loss of tau function on synaptic and cognitive deficits remains poorly understood. We report that old (19-20 months; OKO) but not middle-aged (8-9 months; MKO) tau knock-out mice develop Morris Water Maze (MWM) deficits and loss of hippocampal acetylated α-tubulin and excitatory synaptic proteins. Mild motor deficits and reduction in tyrosine hydroxylase (TH) in the substantia nigra were present by middle age, but did not affect MWM performance, whereas OKO mice showed MWM deficits paralleling hippocampal deficits. Deletion of tau, a microtubule-associated protein (MAP), resulted in increased levels of MAP1A, MAP1B, and MAP2 in MKO, followed by loss of MAP2 and MAP1B in OKO. Hippocampal synaptic deficits in OKO mice were partially corrected with dietary supplementation with docosahexaenoic acid (DHA) and both MWM and synaptic deficits were fully corrected by combining DHA with α-lipoic acid (ALA), which also prevented TH loss. DHA or DHA/ALA restored phosphorylated and total GSK3β and attenuated hyperactivation of the tau C-Jun N-terminal kinases (JNKs) while increasing MAP1B, dephosphorylated (active) MAP2, and acetylated α-tubulin, suggesting improved microtubule stability and maintenance of active compensatory MAPs. Our results implicate the loss of MAP function in age-associated hippocampal deficits and identify a safe dietary intervention, rescuing both MAP function and TH in OKO mice. Therefore, in addition to microtubule-stabilizing therapeutic drugs, preserving or restoring compensatory MAP function may be a useful new prevention strategy.
Copyright © 2014 the authors 0270-6474/14/347124-13$15.00/0.

Entities:  

Keywords:  Alzheimer's disease; MAPs; Morris Water Maze; knock-out; synaptic markers; tau

Mesh:

Substances:

Year:  2014        PMID: 24849348      PMCID: PMC4028492          DOI: 10.1523/JNEUROSCI.3439-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  79 in total

1.  Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport.

Authors:  M Setou; T Nakagawa; D H Seog; N Hirokawa
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

2.  Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model.

Authors:  Bin Zhang; Arpita Maiti; Sharon Shively; Fara Lakhani; Gaye McDonald-Jones; Jennifer Bruce; Edward B Lee; Sharon X Xie; Sonali Joyce; Chi Li; Philip M Toleikis; Virginia M-Y Lee; John Q Trojanowski
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

Review 3.  Long-chain omega-3 fatty acids: time to establish a dietary reference intake.

Authors:  Michael R Flock; William S Harris; Penny M Kris-Etherton
Journal:  Nutr Rev       Date:  2013-10-03       Impact factor: 7.110

4.  Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease.

Authors:  B Hempen; J P Brion
Journal:  J Neuropathol Exp Neurol       Date:  1996-09       Impact factor: 3.685

5.  Microtubule-associated protein 1B: identification of a major component of the neuronal cytoskeleton.

Authors:  G S Bloom; F C Luca; R B Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

6.  Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.

Authors:  Qiu-Lan Ma; Fusheng Yang; Emily R Rosario; Oliver J Ubeda; Walter Beech; Dana J Gant; Ping Ping Chen; Beverly Hudspeth; Cory Chen; Yongle Zhao; Harry V Vinters; Sally A Frautschy; Greg M Cole
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

7.  Age-appropriate cognition and subtle dopamine-independent motor deficits in aged tau knockout mice.

Authors:  Meaghan Morris; Patricia Hamto; Anthony Adame; Nino Devidze; Eliezer Masliah; Lennart Mucke
Journal:  Neurobiol Aging       Date:  2013-01-16       Impact factor: 4.673

8.  Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.

Authors:  Karelle Leroy; Alexis Bretteville; Katharina Schindowski; Emmanuel Gilissen; Michèle Authelet; Robert De Decker; Zehra Yilmaz; Luc Buée; Jean-Pierre Brion
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

9.  A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia.

Authors:  Stephan J Guyenet; Stephanie A Furrer; Vincent M Damian; Travis D Baughan; Albert R La Spada; Gwenn A Garden
Journal:  J Vis Exp       Date:  2010-05-21       Impact factor: 1.355

Review 10.  The MAP2/Tau family of microtubule-associated proteins.

Authors:  Leif Dehmelt; Shelley Halpain
Journal:  Genome Biol       Date:  2004-12-23       Impact factor: 13.583

View more
  49 in total

Review 1.  Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease.

Authors:  Yanina Ivashko Pachima; Liu-yao Zhou; Peng Lei; Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-02       Impact factor: 3.444

2.  Perinatal Lead Exposure Alters Calsyntenin-2 and Calsyntenin-3 Expression in the Hippocampus and Causes Learning Deficits in Mice Post-weaning.

Authors:  Ning Li; Shuai Cao; Zengli Yu; Mingwu Qiao; Yongxia Cheng; Yue Shen; Lianjun Song; Xianqing Huang; Guojun Yang; Yali Zhao
Journal:  Biol Trace Elem Res       Date:  2020-06-16       Impact factor: 3.738

Review 3.  Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease.

Authors:  Jessay Gopuran Devassy; Shan Leng; Melissa Gabbs; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

4.  Lithium suppression of tau induces brain iron accumulation and neurodegeneration.

Authors:  P Lei; S Ayton; A T Appukuttan; S Moon; J A Duce; I Volitakis; R Cherny; S J Wood; M Greenough; G Berger; C Pantelis; P McGorry; A Yung; D I Finkelstein; A I Bush
Journal:  Mol Psychiatry       Date:  2016-07-12       Impact factor: 15.992

Review 5.  Emerging Diagnostic and Therapeutic Strategies for Tauopathies.

Authors:  David Coughlin; David J Irwin
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

6.  Restraint of presynaptic protein levels by Wnd/DLK signaling mediates synaptic defects associated with the kinesin-3 motor Unc-104.

Authors:  Jiaxing Li; Yao V Zhang; Elham Asghari Adib; Doychin T Stanchev; Xin Xiong; Susan Klinedinst; Pushpanjali Soppina; Thomas Robert Jahn; Richard I Hume; Tobias M Rasse; Catherine A Collins
Journal:  Elife       Date:  2017-09-19       Impact factor: 8.140

7.  Loss of tau and Fyn reduces compensatory effects of MAP2 for tau and reveals a Fyn-independent effect of tau on calcium.

Authors:  Guanghao Liu; Ramasamy Thangavel; Jacob Rysted; Yohan Kim; Meghan B Francis; Eric Adams; Zhihong Lin; Rebecca J Taugher; John A Wemmie; Yuriy M Usachev; Gloria Lee
Journal:  J Neurosci Res       Date:  2019-08-26       Impact factor: 4.164

8.  Reduced Adrenomedullin Parallels Microtubule Dismantlement in Frontotemporal Lobar Degeneration.

Authors:  Hilda Ferrero; Ignacio M Larrayoz; Maite Solas; Alfredo Martínez; María J Ramírez; Francisco J Gil-Bea
Journal:  Mol Neurobiol       Date:  2018-04-18       Impact factor: 5.590

Review 9.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

Review 10.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.